Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

(2016) Orrin Devinsky et al.   LANCET NEUROLOGY

Tuberous sclerosis complex

(2016) Elizabeth P. Henske et al.   Nature Reviews Disease Primers

Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy

(2015) Alexandra L. Geffrey et al.   EPILEPSIA

Neurological and neuropsychiatric aspects of tuberous sclerosis complex

(2015) Paolo Curatolo et al.   LANCET NEUROLOGY

Cannabinoids in the Treatment of Epilepsy

(2015) Daniel Friedman et al.   NEW ENGLAND JOURNAL OF MEDICINE

The case for assessing cannabidiol in epilepsy

(2014) Maria Roberta Cilio et al.   EPILEPSIA

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

(2014) Orrin Devinsky et al.   EPILEPSIA

Cannabidiol: Promise and Pitfalls

(2014) Timothy E. Welty et al.   Epilepsy Currents

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures

(2012) Nicholas A. Jones et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Levetiracetam in the treatment of epilepsy

(2011) Bassel Abou-Khalil   Neuropsychiatric Disease and Treatment

The natural history of epilepsy in tuberous sclerosis complex

(2009) Catherine J. Chu-Shore et al.   EPILEPSIA

Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo

(2009) N. A. Jones et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS